Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients

NCT03978208 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: ATB-346 low dose
OTHER: Placebo
DRUG: ATB-346 mid-dose
DRUG: ATB-346 standard dose

Sponsor

Antibe Therapeutics Inc.

Collaborators

[object Object]